M&A Deal Summary

Evolent Health Acquires Integrated Surgical Solutions

On June 29, 2022, Evolent Health acquired business services company Integrated Surgical Solutions from TPG for 375M USD

Acquisition Highlights
  • This is Evolent Health’s 1st transaction in the Business Services sector.
  • This is Evolent Health’s largest (disclosed) transaction.
  • This is Evolent Health’s 5th transaction in the United States.
  • This is Evolent Health’s 1st transaction in Georgia.

M&A Deal Summary

Date 2022-06-29
Target Integrated Surgical Solutions
Sector Business Services
Buyer(s) Evolent Health
Sellers(s) TPG
Deal Type Add-on Acquisition
Deal Value 375M USD

Target

Integrated Surgical Solutions

Alpharetta, Georgia, United States
Integrated Surgical Solutions is a provider of surgical cost management solutions, working with health plans, providers, surgical facilities, device manufacturers, and patients across the country to improve quality and reduce costs for surgical procedures through optimization of the most effective site of care and device selection, resulting in more affordable high-quality care to consumers. Integrated Surgical Solutions was formed in 2004 and is based in Alpharetta, Georgia.

Search 198,242 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Evolent Health

Arlington, Virginia, United States

Category Company
Founded 2011
Sector Information Technology
Employees4,700
Revenue 2.0B USD (2023)
DESCRIPTION

Evolent Health partners with major health systems to drive value-based care transformation. By providing clinical, analytical, and financial capabilities, Evolent helps physicians and systems achieve superior quality and cost results. Evolent Health was founded in 2011 and is based in Arlington, Virginia.


DEAL STATS #
Overall 5 of 6
Sector (Business Services) 1 of 1
Type (Add-on Acquisition) 5 of 5
State (Georgia) 1 of 1
Country (United States) 5 of 6
Year (2022) 1 of 2
Size (of disclosed) 1 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-08-04 Vital Decisions

Edison, New Jersey, United States

Vital Decisions provides proprietary counseling services to advanced illness patients. Vital Decisions' Living Well Program addresses inadequate communication and shared decision-making between patient, provider, and family during a serious illness in order to improve the value and quality of healthcare delivered. Vital Decisions was founded in 2006 and is based in Edison, New Jersey.

Buy $130M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-11-17 Magellan Specialty Health

United States

Magellan Specialty Health is a specialty benefit management organization that offers industry-leading utilization management solutions to health plans, including radiology management, musculoskeletal management, physical medicine management, and genetic testing solutions. Magellan Specialty Health is based in United States.

Buy -

Seller(S) 1

SELLER

TPG

Fort Worth, Texas, United States

Investor Investor Investor Investor


Category Private Equity Firm
Founded 1992
PE ASSETS 137.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

TPG Capital is a global, mega-sized private investment firm that manages a family of funds focused on private equity, real estate, venture capital, public equity and debt investing. TPG invests in opportunities across a broad range of industries and geographies. TPG generally seeks to invest in established businesses that can benefit from the Firm's operational experience and connections. Industries of interest include consumer, retail, healthcare, industrials, digital media, natural resources, energy, real estate, technology, and software. TPG was formerly known as Texas Pacific Group and was originally established in 1992 by David Bonderman, James Coulter and William Price. The Firm is based in Forth Worth, Texas with additional offices in Europe, Asia, and Australia.


DEAL STATS #
Overall 239 of 248
Sector (Business Services) 8 of 9
Type (Add-on Acquisition) 85 of 89
State (Georgia) 5 of 6
Country (United States) 176 of 183
Year (2022) 3 of 5
Size (of disclosed) 54 of 71
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-05-25 Covetrus

Portland, Maine, United States

Covetrus is a provider of technology-enabled healthcare services for companion and equine veterinary practitioners. The company partners with veterinarians to create insight into gaps in patient care and offer professionalized pro-active prescription management to drive client engagement and improve compliance. Covetrus was formed in 2010 and is based in Portland, Maine.

Buy $4.0B
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-06-30 Doc Generici

Milan, Italy

Doc Generici provides drugs for the treatment of common medical conditions with a broad product portfolio and a strong presence in areas including cardiovascular, gastrointestinal/metabolism and neurological treatments. Doc Generici operates an asset-light model and benefits from a consolidated network of suppliers. Doc Generici was founded in 1996 and is based in Milan, Italy.

Buy -